(9R)-9-chloro-11-17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10-13-16-trimethyl-6-7-8-11-12-14-15-16-octahydrocyclopenta[a]phenanthren-3-one has been researched along with Lichen-Planus--Oral* in 1 studies
1 other study(ies) available for (9R)-9-chloro-11-17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10-13-16-trimethyl-6-7-8-11-12-14-15-16-octahydrocyclopenta[a]phenanthren-3-one and Lichen-Planus--Oral
Article | Year |
---|---|
Prescribing for mucosal disease in primary dental care.
Oral mucosal disease has a variety of causes, some of which are due to dysfunction of the immune system. Recurrent aphthous stomatitis and oral lichen planus are the mucosal diseases of unknown cause seen most frequently in dental practice, and the most likely mucosal diseases for which a dentist will prescribe. This paper briefly reviews the clinical features of these conditions, their causation and pertinent information for managing them in a primary care setting. The prescribing of appropriate medications to treat the conditions in a general dental practice is described and discussed. Topics: Anesthetics, Local; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Beclomethasone; Benzydamine; Betamethasone; Chlorhexidine; Doxycycline; Drug Prescriptions; Humans; Hydrocortisone; Lichen Planus, Oral; Lidocaine; Mouthwashes; Recurrence; Stomatitis, Aphthous | 2014 |